Akèy › Dematit atopik (Ekzema) › Pennsylvania
Etid klinik pou Dematit atopik (Ekzema) nan Pennsylvania
13 etid pou Dematit atopik (Ekzema) ap chèche patisipan nan sit nan Pennsylvania.
Vil nan Pennsylvania
Tèks ofisyèl etid la (Anglè)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- UPMC - Department of Dermatology- Site Number : 8400024, Pittsburgh
Ap rekriteEtid obsèvasyon
Laj 12 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07290803Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Camp Hill
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT07298395A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Paddington Testing Co, Inc, Philadelphia
- UPMC Department of Dermatology, Pittsburgh
Ap rekriteFaz 2
Laj 18 a 64 · Tout sèks · Mizajou Sep 25, 2026 · NCT07216027A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Pittsburgh
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07003425A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
- Best Skin Research LLC, Camp Hill
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07223697A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Best Skin Research, LLC, Camp Hill
- UPMC Department of Dermatology, Pittsburgh
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Aug 28, 2026 · NCT07599813FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- Paddington Testing Company, Philadelphia
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Jul 22, 2026 · NCT06564389A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Clinical Research of Philadelphia /ID# 264972, Philadelphia
- University of Pittsburgh Medical Center /ID# 264526, Pittsburgh
- Dermatology Associates of Plymouth Meeting /ID# 267286, Plymouth Meeting
Ap rekriteFaz 3
Laj 18 a 63 · Tout sèks · Mizajou Jul 6, 2026 · NCT06389136The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis
- University of Pittsburgh Medical Center, Pittsburgh
- UPMC Department of Dermatology, Pittsburgh
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou May 4, 2026 · NCT06928246A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Paddington Testing Co, Inc, Philadelphia
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 4, 2026 · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 8559, Philadelphia
- Galderma Investigational Site 7103, Philadelphia
Ap rekriteEtid obsèvasyon
Laj 12 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT06988605Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- University of Pittsburgh Medical Center, Pittsburgh
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Dec 30, 2025 · NCT00177268A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
- DermDox Centers for Dermatology, Camp Hill
- University of Pennsylvania, Philadelphia
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 19, 2025 · NCT06055361Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.